# Bioventus to acquire Misonix for $518 million

Bioventus will acquire Misonix in a cash-and-stock transaction valued at approximately $518 million, adding minimally invasive ultrasonic technologies and regenerative medicine products.

- Type: Acquisition
- Announced: 2021-07-29
- Where: United States
- Value: $518.0M
- Status: announced
- Products: minimally invasive ultrasonic technologies, regenerative medicine wound products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Misonix](https://endata.com/companies/28191.md) (target)
- [Bioventus Inc.](https://endata.com/companies/54140.md) (acquirer)

## Sources

- [ir.bioventus.com](https://ir.bioventus.com/news-releases/news-release-details/bioventus-and-misonix-announce-definitive-agreement-bioventus/), 2021-07-29: "The Combination Further Differentiates Bioventus’ Product Portfolio and Accelerates Its Revenue Growth"
- [healio.com](https://www.healio.com/news/orthopedics/20210730/bioventus-enters-agreement-to-acquire-misonix), 2021-07-30: "We are excited to further establish Bioventus as a differentiated, growth-focused medical technology company with deep and broad capabilities across a range of care settings and specialties."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.